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We describe a fatal pediatric case of Rocky Mountain 
spotted fever in Panama, the ﬁ  rst, to our knowledge, since 
the 1950s. Diagnosis was established by immunohisto-
chemistry, PCR, and isolation of Rickettsia rickettsii from 
postmortem tissues. Molecular typing demonstrated strong 
relatedness of the isolate to strains of R. rickettsii from Cen-
tral and South America.
R
ocky Mountain spotted fever (RMSF) is a febrile ex-
anthematic disease caused by Rickettsia rickettsii, a 
gram-negative, obligately intracellular pathogen. R. rickett-
sii primarily invades the endothelium of small and medium-
sized blood vessels of all major tissues and organ systems, 
causing systemic vasculitis. Typical symptoms include 
headache, fever, rash, and myalgia; meningoencephalitis 
and renal failure may also occur. The case-fatality rate of 
untreated RMSF in different areas is 10%–80%.
RMSF is endemic in much of the Western Hemisphere, 
including Central and South America. In Panama, 5 cases 
of RMSF, 2 fatal, were reported in the 1950s from the vi-
cinity of Ollas Arriba, Trans-Istmus Highway, and Panama 
City (1–4).
In 1952, R. rickettsii was isolated from 2 of the patients 
who died and from a pool of Amblyomma cajennense ticks 
from the Ollas Arriba area, ﬁ  ndings that suggest that this 
tick is a vector of RMSF in Panama (2). In 1961, R. rick-
ettsii was isolated from a pool of 20 immature Amblyom-
ma ticks collected from an opossum and a lizard from the 
Canal Zone (5). Serosurveillance of 1,400 samples tested 
by complement ﬁ  xation with R. rickettsii antigen in 1951–
1952 detected 5.4%–15.2% seropositivity in 9 provinces of 
Panama (6). We describe here a recent fatal pediatric case 
of RMSF, the ﬁ  rst report, to our knowledge, of this disease 
in Panama since the 1950s.
The Patient
On December 18, 2004, a 4-year-old female patient 
from a rural area west of the Panama Canal was admitted 
to Hospital del Niño, Panama City, Panama, with an 8-day 
history of intense headache, fever, malaise, myalgia, and 
arthralgia of the lower extremities and 3 days of general-
ized petechial rash. Ceftriaxone was administered empiri-
cally for suspected meningococcemia. Laboratory tests 
showed hyponatremia (126 mEq/L), hypoalbuminemia (2 
g/dL), thrombocytopenia (48 × 109 cells/L), increased im-
mature neutrophils (26%), and an elevated level of liver 
enzymes (aspartate aminotransferase 325 U/L and alanine 
aminotransferase 137 U/L). Results of routine blood cul-
tures were negative. Cerebrospinal ﬂ  uid analysis showed 
only protein elevation. Serologic test results for equine 
encephalitis virus, dengue, hantavirus, and calicivirus as 
well as bacterial cultures were all negative. On December 
18, the patient had seizures, which required intensive care 
management. Despite intense medical efforts, she died soon 
thereafter. The main autopsy ﬁ  ndings included myocarditis, 
interstitial nephritis, interstitial pneumonitis, encephalitis, 
and generalized lymphadenitis. Postmortem frozen unﬁ  xed 
and formalin-ﬁ  xed tissues were sent to the US Centers for 
Disease Control and Prevention for etiologic assessment.
Immunohistochemical evaluation of formalin-ﬁ  xed, 
parafﬁ   n-embedded tissues that used an immunoalkaline 
phosphatase technique demonstrated spotted fever group 
rickettsial antigens associated with rickettsia-like cells in 
vascular endothelium of multiple tissues, including heart 
(Figure 1), lung, adrenal gland, and kidney. Serum col-
lected on the day of death had immunoglobulin (Ig) G and 
IgM microimmunoﬂ  uoresence antibody titers of 2,048 to 
R. rickettsii antigen. DNA samples prepared from frozen 
brain, liver, lymph node, and spleen autopsy specimens 
were tested by PCR as described previously (7). When am-
pliﬁ  ed, a 208-bp fragment of the conserved 17-kDa Rick-
ettsia antigen gene showed spotted fever rickettsial DNA 
was present in all autopsy tissues. An OmpA gene fragment 
(70–602 nt) was ampliﬁ  ed from brain and lymph node tis-
sues (GenBank accession nos. DQ002503 and DQ002504). 
DNA sequencing of the ompA amplicons demonstrated 
that their nucleotide sequences were identical to each oth-
er and had 100% sequence similarity to the homologous 
ompA fragment of R. rickettsii strain Sheila Smith, isolated 
from a patient in Montana. An isolate of R. rickettsii (des-
ignated Panama 2004) was obtained from brain tissue in 
Vero E6 cells; its OmpA gene fragment (DQ164838) had 
100% nucleotide sequence similarity to the reference se-
quence of R. rickettsii type strain Sheila Smith. R. rickett-
sii from Panama is similar to the other R. rickettsii strains 
circulating in Central and South America but differs from 
strain Sheila Smith in at least 1 locus containing tandemly 
repeated sequences (Figure 2).
The clinical characteristics of this patient, e.g., fever, 
headache, myalgia, petechial rash, and neurologic signs, 
initially aroused clinical suspicion for a viral fever caused 
by Venezuelan equine encephalitis (VEE) virus, particu-
larly because there was a VEE outbreak in this area at that 
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time. The failure to diagnose a spotted fever rickettsiosis 
was partially the result of diminished awareness of RMSF 
among local physicians and absence of adequate speciﬁ  c 
diagnostic tests in Panama. Detection of hyponatremia, 
hypoalbuminemia, and thrombocytopenia, all observed 
in this patient, indicates endothelial vascular damage and 
increased vascular permeability and can aid in making a 
presumptive diagnosis (8). Death secondary to RMSF is 
associated with delays in diagnosis and delays in initiating 
appropriate antimicrobial therapy within the ﬁ  rst 5 days of 
the clinical disease (9). To prevent fatal outcomes, treat-
ment of suspected case-patients should be initiated before 
the results of diagnostic tests are received, and treatment 
should be administered for 7–10 days or until the patient 
has been without fever for at least 3 days (9).
R. rickettsii had been isolated previously in Panama 
from a few patients during the 1950s and from pools of A. 
cajennense ticks during the 1950s and 1960s (1,2,5). As 
occurred in this instance, cases of RMSF have likely been 
missed in Panama during the intervening decades; however, 
the low frequency of recognized cases of RMSF does not 
correspond to the relatively high seroprevalence of com-
plement-ﬁ  xing antibodies to spotted fever group rickettsiae 
in residents of Panama (6). Indeed, inoculation of other 
pools from Amblyomma larvae and A. cajennense adults 
caused seroconversion to spotted fever group antigens in 
guinea pigs, but R. rickettsii was not isolated (5). Recent 
studies of Amblyomma ticks in Brazil have detected both 
R. bellii and an agent associated with A. americanum in 
the United States known as “Rickettsia amblyommii” (10). 
R. amblyommii has been implicated as a cause of a mild, 
self-limiting rickettsial illness in which seroconversion to 
R. rickettsii antigens occurs (11,12). R. parkeri, found in A. 
maculatum and A. triste, has been also identiﬁ  ed as a cause 
of disease in the United States and has been presumptive-
ly associated with infections of humans in Uruguay (13). 
Since the characterization of rickettsial agents associated 
with Amblyomma species that bite humans is a newly emer-
gent ﬁ  eld in the Americas (13–15), other typhus group and 
spotted fever group agents may be found in Panama.
Conclusions
This case conﬁ  rms that R. rickettsii is still present in 
Panama. A high index of suspicion is necessary for an early 
diagnosis and empiric treatment of RMSF. Proposed wid-
ening of the Panama Canal and current construction of a 
new portion of the Trans-Istmus Highway disrupts the ad-
jacent forest areas and would likely increase the frequency 
of human–tick contacts. Thus, RMSF should be considered 
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Figure 1. Histologic and immunohistochemical evaluation of heart 
tissue. A) Lymphohistiocytic inﬂ   ammatory cell inﬁ   ltrates in the 
myocardium (hematoxylin and eosin stain; original magniﬁ  cation 
×25). B) Immunohistochemical detection of spotted fever group 
rickettsiae (red) in perivascular inﬁ  ltrates of heart (immunoalkaline 
phosphatase with naphthol-fast red substrate and hematoxylin 
counterstain; original magniﬁ  cation ×250).
Figure 2. Differentiation of Rickettsia rickettsii type strain Sheila 
Smith from Montana from R. rickettsii strains from Central and South 
America. A tandem repeat region corresponding to 563048–563028 
nt of the strain Sheila Smith genome and ﬂ  anking  sequences 
were ampliﬁ  ed with AF (5′-GTGATTGCTATATTTCGCTTT-3′) and 
AR (5′- CTAAGATTTGTTCCGTATAGG-3′) primers as described 
elsewhere (7). Repeat sequence (GCCTTAT, indicated with 
brackets) present in 3 copies in strain Sheila Smith, whereas only 2 
copies were present in R. rickettsii isolates from Brazil, Colombia, 
Costa Rica, and Panama. Homologous sequences of these 
strains are deposited to GenBank under the following accession 
nos.: DQ666020, R. rickettsii strain Panama 2004; DQ666021, 
R. rickettsii strain Brazil; DQ666022, R. rickettsii strain Colombia; 
DQ666023, and R. rickettsii strain Costa Rica.Rocky Mountain Spotted Fever, Panama
early in the differential diagnosis of febrile infections in 
tick-exposed persons in Panama. Further study of endemic 
rickettsioses, rickettsial agents, and possible tick vectors in 
Panama is warranted.
Dr Estripeaut is a pediatric infectious disease fellow at the 
Hospital del Niño, Panama. She specializes in tropical infectious 
diseases.
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